Prot #7465-CL-202: An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Project: Research project

Project Details

StatusActive
Effective start/end date11/23/20 → 11/23/26

Funding

  • Parexel (Prot #7465-CL-202 // Prot #7465-CL-202)
  • Astellas Pharma Global Development, Inc. (Prot #7465-CL-202 // Prot #7465-CL-202)